Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119142342 | 11914234 | 2 | F | 19990427 | 20160826 | 20160113 | 20160826 | EXP | FR-BRISTOL-MYERS SQUIBB COMPANY-10706133 | BRISTOL MYERS SQUIBB | 0.00 | F | Y | 0.00000 | 20160826 | CN | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119142342 | 11914234 | 1 | PS | ZERIT | STAVUDINE | 1 | Oral | UNK | U | 20412 | CAPSULE, HARD | ||||||||
| 119142342 | 11914234 | 2 | SS | EPIVIR | LAMIVUDINE | 1 | Unknown | U | 0 | ||||||||||
| 119142342 | 11914234 | 3 | SS | VIRAMUNE | NEVIRAPINE | 1 | Unknown | 2 DF, BID | U | 0 | 2 | DF | BID | ||||||
| 119142342 | 11914234 | 4 | SS | RETROVIR | ZIDOVUDINE | 1 | Intravenous (not otherwise specified) | UNK | U | 0 | |||||||||
| 119142342 | 11914234 | 5 | C | CLAMOXYL | AMOXICILLINCLAVULANIC ACID | 1 | Unknown | U | 0 | ||||||||||
| 119142342 | 11914234 | 6 | C | ECONAZOLE | ECONAZOLE | 1 | Unknown | U | 0 | ||||||||||
| 119142342 | 11914234 | 7 | C | ROVAMYCINE | SPIRAMYCIN | 1 | Unknown | U | 0 | ||||||||||
| 119142342 | 11914234 | 8 | C | CHLORQUINALDOL + PROMESTRIENE | 2 | Unknown | U | 0 | |||||||||||
| 119142342 | 11914234 | 9 | C | SPASFON | PHLOROGLUCINOL | 1 | Unknown | U | 0 | ||||||||||
| 119142342 | 11914234 | 10 | C | TARDYFERON | FERROUS SULFATE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119142342 | 11914234 | 1 | Antiretroviral therapy |
| 119142342 | 11914234 | 2 | Antiretroviral therapy |
| 119142342 | 11914234 | 3 | Antiretroviral therapy |
| 119142342 | 11914234 | 4 | Antiretroviral therapy |
| 119142342 | 11914234 | 5 | Product used for unknown indication |
| 119142342 | 11914234 | 6 | Product used for unknown indication |
| 119142342 | 11914234 | 7 | Product used for unknown indication |
| 119142342 | 11914234 | 8 | Product used for unknown indication |
| 119142342 | 11914234 | 9 | Product used for unknown indication |
| 119142342 | 11914234 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119142342 | 11914234 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119142342 | 11914234 | Anaemia | |
| 119142342 | 11914234 | Caesarean section | |
| 119142342 | 11914234 | Live birth | |
| 119142342 | 11914234 | Pregnancy | |
| 119142342 | 11914234 | Sickle cell anaemia | |
| 119142342 | 11914234 | Toxoplasmosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |